Biohaven Ltd (BHVN) Stock Price & News - Google Finance

The range between the high and low prices over the past 52 weeks. $26.80 - $62.21. Market cap. A valuation method that multiplies the price of a company's stock by the total number of …

CouponFollow Extension

$26.80
OFF

Biohaven Ltd (BHVN) Stock Price & News - Google Finance

1 week from now

The range between the high and low prices over the past 52 weeks. $26.80 - $62.21. Market cap. A valuation method that multiplies the price of a company's stock by the total number of …

google.com

16%
OFF

Biohaven Ltd. (BHVN) Stock Price, News, Quote & History - Yahoo …

1 week from now

82.57. -1.16%. RYTM Rhythm Pharmaceuticals, Inc. 47.08. -1.34%. Find the latest Biohaven Ltd. (BHVN) stock quote, history, news and other vital information to help you with your stock …

yahoo.com

8%
OFF

Biohaven (NYSE:BHVN) Shares Down 8% - Here's What Happened

1 week from now

1 day ago · November 16, 2024. Biohaven Ltd. (NYSE:BHVN - Get Free Report)'s share price was down 8% on Friday . The stock traded as low as $44.68 and last traded at $44.76. …

marketbeat.com

$150
OFF

BHVN Stock Price | Biohaven Ltd. Stock Quote (U.S.: NYSE)

1 week from now

6 days ago · Biohaven Pharmaceutical stock price target raised to $150 from $101 at BMO Capital. Aug. 3, 2021 at 9:20 a.m. ET by Tomi Kilgore.

marketwatch.com

05%
OFF

Biohaven Ltd, BHVN:NYQ Summary - FT.com - Financial Times

1 week from now

Nov 9, 2024 · On Saturday, Biohaven Ltd (BHVN:NYQ) closed at 53.47, -14.05% below its 52-week high of 62.21, set on Mar 08, 2024. Data delayed at least 15 minutes, as of Nov 09 …

ft.com

90%
OFF

Biohaven Ltd. (BHVN) Receives A Buy From Morgan Stanley

1 week from now

2 days ago · Currently, the analyst consensus on Biohaven Ltd. is a Strong Buy with an average price target of $65.64, a 34.90% upside from current levels. In a report released on November …

businessinsider.com

$66
OFF

Biohaven Price Target Lowered To $66 From $68 At RBC Capital

1 week from now

3 days ago · November 13, 2024 — 08:36 am EST. Written by TheFly for TipRanks ->. RBC Capital lowered the firm’s price target on Biohaven (BHVN) to $66 from $68 and keeps an …

nasdaq.com

$5.48
OFF

Bioharvest Sciences Inc (BHST) Stock Price & News - Google Finance

1 week from now

The range between the high and low prices over the past day. $5.48 - $6.00. Year range. The range between the high and low prices over the past 52 weeks. $4.03 - $7.70. Market cap. A …

google.com

FAQs about Biohaven Ltd (BHVN) Stock Price & News - Google Finance Coupon?

What is the price of bhvn Biohaven Ltd?

BHVN Biohaven Ltd. Stock Price & Overview Follow $52.840.48(+0.92%)4:00 PM 10/25/24 NYSE |$USD |Pre-Market:$53.06+0.22(+0.42%)4:46 AM Summary Ratings Financials Earnings Dividends Valuation Growth Profitability Momentum Peers Options Charting All Analysis Comments News Transcripts SEC Filings Press Releases Related Analysis BHVN Stock Price 1D 5D ...

What does bhvn stand for?

Find the latest Biohaven Ltd. (BHVN) stock quote, history, news and other vital information to help you with your stock trading and investing. ...

Why did Biohaven (bhvn) stock rise 15% Monday?

Biohaven (BHVN) shares soared 15% Monday after the biotech firm announced positive results from a study of its experimental treatment for a rare neurological condition. ...

Is bhvn a good stock to buy?

BHVN is trading within a range we consider fairly valued. Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. ...

Is Biohaven Ltd (bhvn) ripe for a trend reversal?

The heavy selling pressure might have exhausted for Biohaven Ltd. (BHVN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal. ...

Where is Biohaven headquartered?

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT. BHVN | Complete Biohaven Ltd. stock news by MarketWatch. ...